REMICADE subst sèche 100 mg flac
7680551840015
CH-55184
L04AB02
07.15.0.
Reimbursement limitations:
REMICADE2
Le traitement par REMICADE exige une garantie préalable de prise en charge des coûts par …
1 / 3
google
Details
- Product number
- 5518401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: infliximabum 100 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, saccharum, polysorbatum 80, pro vitro corresp. natrium 1.943 mg.
Articles (1)
Remicade, Lyophilisat
Lyophilisat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
1.943 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 565.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2000
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 55184
- Drug name
- Remicade, Lyophilisat
- Galenic form
- LSPA
- ATC Code
- L04AB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/12/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REMICADE subst sèche 100 mg flac
- Description (DE)
- REMICADE Trockensub 100 mg Durchstf
- Market launch
- 21/12/1999
- Narcotic (BTM)
- No